Primary Site >> Stomach Cancer
Gene >> UGT1A1
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Pharmacogenetics of stomach cancer. PMID: 12914384 |
Ref: Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer PMID: 19513514 |
Ref: Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results. PMID: 20860988 Ref: An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells. PMID: 21997136 |
Ref: Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer. PMID: 22516947 |
Ref: Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy. PMID: 23303296 Ref: Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients. PMID: 23783485 Ref: CPT-11 as a second-line treatment for patients with advanced/metastatic gastric cancer who failed S-1 (CCOG0702). PMID: 23881212 Ref: A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma. PMID: 24129235 |
Ref: Differential expression of the UGT1A family of genes in stomach cancer tissues. PMID: 25712374 |
Ref: Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer. PMID: 26872008 |
Ref: Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. PMID: 28056823 Ref: Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer. PMID: 28209749 Ref: Analysis of 12 variants in the development of gastric and colorectal cancers. PMID: 29358861 |